Maxidex (Dexamethasone)

Dexamethasone binds to intracellular glucocorticoid receptors in ocular tissues. The activated receptor complex alters gene transcription, leading to decreased production of inflammatory mediators, reduced leukocyte migration, and lowered vascular permeability, which together provide potent anti‑inflammatory and immunosuppressive effects.

The dosing regimen for Maxidex is determined by the prescribing clinician based on the specific indication, severity of inflammation and patient response. Typical regimens may involve one to several drops per eye per day, but the exact schedule should be individualized by a qualified healthcare professional.

Safety data for dexamethasone ophthalmic use in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing patients.

To request Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Maxidex contains dexamethasone, a high‑potency glucocorticoid, offering strong anti‑inflammatory activity compared with lower‑potency agents such as prednisolone acetate. Its formulation provides rapid ocular penetration, but like all potent steroids it carries a higher risk of intra‑ocular pressure elevation and cataract formation, requiring careful monitoring.

Maxidex should be stored at room temperature, preferably below 25 °C, in its original container. Keep the bottle tightly closed, protect it from direct light and moisture, and avoid freezing. Do not use the product if the solution appears discolored or contains particles.

Maxidex is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and instill the prescribed number of drops into the conjunctival sac. The eye should be gently closed for a few seconds to allow absorption.

Serious risks include a significant rise in intra‑ocular pressure that can lead to glaucoma, development of cataracts with prolonged use, and secondary ocular infections such as bacterial, fungal or viral keratitis. Patients should be monitored regularly for visual changes, eye pain or redness.

Maxidex is contraindicated in patients with known hypersensitivity to dexamethasone or any component of the formulation, and it should be avoided in eyes with active viral, fungal or severe bacterial infections. Caution is also advised for individuals with uncontrolled glaucoma or a history of steroid‑induced pressure spikes.